Microorganisms (Mar 2021)

A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings

  • Prakash Ghosh,
  • Abhijit Sharma,
  • Narayan Raj Bhattarai,
  • Kumar Abhishek,
  • Thilini Nisansala,
  • Amresh Kumar,
  • Susanne Böhlken-Fascher,
  • Rajashree Chowdhury,
  • Md Anik Ashfaq Khan,
  • Khaledul Faisal,
  • Faria Hossain,
  • Md. Rasel Uddin,
  • Md. Utba Rashid,
  • Shomik Maruf,
  • Keshav Rai,
  • Monica Sooriyaarachchi,
  • Withanage Lakma Kumari Abhayarathna,
  • Prahlad Karki,
  • Shiril Kumar,
  • Shalindra Ranasinghe,
  • Basudha Khanal,
  • Satyabrata Routray,
  • Pradeep Das,
  • Dinesh Mondal,
  • Ahmed Abd El Wahed

DOI
https://doi.org/10.3390/microorganisms9030588
Journal volume & issue
Vol. 9, no. 3
p. 588

Abstract

Read online

With the advancement of isothermal nucleic acid amplification techniques, detection of the pathogenic DNA in clinical samples at point-of-need is no longer a dream. The newly developed recombinase polymerase amplification (RPA) assay incorporated in a suitcase laboratory has shown promising diagnostic efficacy over real-time PCR in detection of leishmania DNA from clinical samples. For broader application of this point-of-need system, we undertook a current multi-country diagnostic evaluation study towards establishing this technique in different endemic settings which would be beneficial for the ongoing elimination programs for leishmaniasis. For this study purpose, clinical samples from confirmed visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL) patients were subjected to both real-time PCR and RPA assay in Bangladesh, India, and Nepal. Further skin samples from confirmed cutaneous leishmaniasis (CL) patients were also included from Sri Lanka. A total of 450 clinical samples from VL patients, 429 from PKDL patients, 47 from CL patients, and 322 from endemic healthy/healthy controls were under investigation to determine the diagnostic efficacy of RPA assay in comparison to real-time PCR. A comparative sensitivity of both methods was found where real-time PCR and RPA assay showed 96.86% (95% CI: 94.45–98.42) and 88.85% (95% CI: 85.08–91.96) sensitivity respectively in the diagnosis of VL cases. This new isothermal method also exhibited promising diagnostic sensitivity (93.50%) for PKDL cases, when a skin sample was used. Due to variation in the sequence of target amplicons, RPA assay showed comparatively lower sensitivity (55.32%) than that of real-time PCR in Sri Lanka for the diagnosis of CL cases. Except for India, the assay presented absolute specificity in the rest of the sites. Excellent concordance between the two molecular methods towards detection of leishmania DNA in clinical samples substantiates the application of RPA assay incorporated in a suitcase laboratory for point-of-need diagnosis of VL and PKDL in low resource endemic settings. However, further improvisation of the method is necessary for diagnosis of CL.

Keywords